Regulation of the Pharmaceutical Industry
- 1 December 1992
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 2 (6), 435-439
- https://doi.org/10.2165/00019053-199202060-00002
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Cost effectiveness/utility analyses: Do current decision rules lead us to where we want to be?Journal of Health Economics, 1992
- Discounting of Health Benefits in the Pharmacoeconomic Analysis of Drug TherapiesPharmacoEconomics, 1992
- Cost‐effectiveness guidelines for reimbursement of pharmaceuticals: Is economic evaluation ready for its enhanced status?Health Economics, 1992
- Discounting and health benefits: Another PerspectiveHealth Economics, 1992
- Discounting and health benefitsHealth Economics, 1992
- Economic Analysis as an Aid to Subsidisation DecisionsPharmacoEconomics, 1992
- Avoiding Bias in the Conduct and Reporting of Cost-Effectiveness Research Sponsored by Pharmaceutical CompaniesNew England Journal of Medicine, 1991